Market Intelligence chevron_right Medical Care chevron_right Small Molecule Drug CDMO
Global Report 2025

Global Small Molecule Drug CDMO Market Growth (Status and Outlook) 2025-2031

calendar_todayPublished: Jun 2025 descriptionPages: 135 categoryCategory: Medical Care
cloud_downloadRequest Sample Report
mailPre-Order Enquiry
local_offerGet Discount 
1 Scope of the Report
 1.1 Market Introduction
 1.2 Years Considered
 1.3 Research Objectives
 1.4 Market Research Methodology
 1.5 Research Process and Data Source
 1.6 Economic Indicators
 1.7 Currency Considered
 1.8 Market Estimation Caveats
2 Executive Summary
 2.1 World Market Overview
 2.1.1 Global Small Molecule Drug CDMO Market Size (2020-2031)
 2.1.2 Small Molecule Drug CDMO Market Size CAGR by Region (2020 VS 2024 VS 2031)
 2.1.3 World Current & Future Analysis for Small Molecule Drug CDMO by Country/Region (2020, 2024 & 2031)
 2.2 Small Molecule Drug CDMO Segment by Type
 2.2.1 FDF CDMO
 2.2.2 Packaging CDMO
 2.2.3 Clinical CDMO
 2.3 Small Molecule Drug CDMO Market Size by Type
 2.3.1 Small Molecule Drug CDMO Market Size CAGR by Type (2020 VS 2024 VS 2031)
 2.3.2 Global Small Molecule Drug CDMO Market Size Market Share by Type (2020-2025)
 2.4 Small Molecule Drug CDMO Segment by Application
 2.4.1 Pharmaceutical Company
 2.4.2 Biotechnology Company
 2.4.3 Other
 2.5 Small Molecule Drug CDMO Market Size by Application
 2.5.1 Small Molecule Drug CDMO Market Size CAGR by Application (2020 VS 2024 VS 2031)
 2.5.2 Global Small Molecule Drug CDMO Market Size Market Share by Application (2020-2025)
3 Small Molecule Drug CDMO Market Size by Player
 3.1 Small Molecule Drug CDMO Market Size Market Share by Player
 3.1.1 Global Small Molecule Drug CDMO Revenue by Player (2020-2025)
 3.1.2 Global Small Molecule Drug CDMO Revenue Market Share by Player (2020-2025)
 3.2 Global Small Molecule Drug CDMO Key Players Head office and Products Offered
 3.3 Market Concentration Rate Analysis
 3.3.1 Competition Landscape Analysis
 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 3.4 New Products and Potential Entrants
 3.5 Mergers & Acquisitions, Expansion
4 Small Molecule Drug CDMO by Region
 4.1 Small Molecule Drug CDMO Market Size by Region (2020-2025)
 4.2 Global Small Molecule Drug CDMO Annual Revenue by Country/Region (2020-2025)
 4.3 Americas Small Molecule Drug CDMO Market Size Growth (2020-2025)
 4.4 APAC Small Molecule Drug CDMO Market Size Growth (2020-2025)
 4.5 Europe Small Molecule Drug CDMO Market Size Growth (2020-2025)
 4.6 Middle East & Africa Small Molecule Drug CDMO Market Size Growth (2020-2025)
5 Americas
 5.1 Americas Small Molecule Drug CDMO Market Size by Country (2020-2025)
 5.2 Americas Small Molecule Drug CDMO Market Size by Type (2020-2025)
 5.3 Americas Small Molecule Drug CDMO Market Size by Application (2020-2025)
 5.4 United States
 5.5 Canada
 5.6 Mexico
 5.7 Brazil
6 APAC
 6.1 APAC Small Molecule Drug CDMO Market Size by Region (2020-2025)
 6.2 APAC Small Molecule Drug CDMO Market Size by Type (2020-2025)
 6.3 APAC Small Molecule Drug CDMO Market Size by Application (2020-2025)
 6.4 China
 6.5 Japan
 6.6 South Korea
 6.7 Southeast Asia
 6.8 India
 6.9 Australia
7 Europe
 7.1 Europe Small Molecule Drug CDMO Market Size by Country (2020-2025)
 7.2 Europe Small Molecule Drug CDMO Market Size by Type (2020-2025)
 7.3 Europe Small Molecule Drug CDMO Market Size by Application (2020-2025)
 7.4 Germany
 7.5 France
 7.6 UK
 7.7 Italy
 7.8 Russia
8 Middle East & Africa
 8.1 Middle East & Africa Small Molecule Drug CDMO by Region (2020-2025)
 8.2 Middle East & Africa Small Molecule Drug CDMO Market Size by Type (2020-2025)
 8.3 Middle East & Africa Small Molecule Drug CDMO Market Size by Application (2020-2025)
 8.4 Egypt
 8.5 South Africa
 8.6 Israel
 8.7 Turkey
 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
 9.1 Market Drivers & Growth Opportunities
 9.2 Market Challenges & Risks
 9.3 Industry Trends
10 Global Small Molecule Drug CDMO Market Forecast
 10.1 Global Small Molecule Drug CDMO Forecast by Region (2026-2031)
 10.1.1 Global Small Molecule Drug CDMO Forecast by Region (2026-2031)
 10.1.2 Americas Small Molecule Drug CDMO Forecast
 10.1.3 APAC Small Molecule Drug CDMO Forecast
 10.1.4 Europe Small Molecule Drug CDMO Forecast
 10.1.5 Middle East & Africa Small Molecule Drug CDMO Forecast
 10.2 Americas Small Molecule Drug CDMO Forecast by Country (2026-2031)
 10.2.1 United States Market Small Molecule Drug CDMO Forecast
 10.2.2 Canada Market Small Molecule Drug CDMO Forecast
 10.2.3 Mexico Market Small Molecule Drug CDMO Forecast
 10.2.4 Brazil Market Small Molecule Drug CDMO Forecast
 10.3 APAC Small Molecule Drug CDMO Forecast by Region (2026-2031)
 10.3.1 China Small Molecule Drug CDMO Market Forecast
 10.3.2 Japan Market Small Molecule Drug CDMO Forecast
 10.3.3 Korea Market Small Molecule Drug CDMO Forecast
 10.3.4 Southeast Asia Market Small Molecule Drug CDMO Forecast
 10.3.5 India Market Small Molecule Drug CDMO Forecast
 10.3.6 Australia Market Small Molecule Drug CDMO Forecast
 10.4 Europe Small Molecule Drug CDMO Forecast by Country (2026-2031)
 10.4.1 Germany Market Small Molecule Drug CDMO Forecast
 10.4.2 France Market Small Molecule Drug CDMO Forecast
 10.4.3 UK Market Small Molecule Drug CDMO Forecast
 10.4.4 Italy Market Small Molecule Drug CDMO Forecast
 10.4.5 Russia Market Small Molecule Drug CDMO Forecast
 10.5 Middle East & Africa Small Molecule Drug CDMO Forecast by Region (2026-2031)
 10.5.1 Egypt Market Small Molecule Drug CDMO Forecast
 10.5.2 South Africa Market Small Molecule Drug CDMO Forecast
 10.5.3 Israel Market Small Molecule Drug CDMO Forecast
 10.5.4 Turkey Market Small Molecule Drug CDMO Forecast
 10.6 Global Small Molecule Drug CDMO Forecast by Type (2026-2031)
 10.7 Global Small Molecule Drug CDMO Forecast by Application (2026-2031)
 10.7.1 GCC Countries Market Small Molecule Drug CDMO Forecast
11 Key Players Analysis
 11.1 Lonza
 11.1.1 Lonza Company Information
 11.1.2 Lonza Small Molecule Drug CDMO Product Offered
 11.1.3 Lonza Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2020-2025)
 11.1.4 Lonza Main Business Overview
 11.1.5 Lonza Latest Developments
 11.2 Catalent
 11.2.1 Catalent Company Information
 11.2.2 Catalent Small Molecule Drug CDMO Product Offered
 11.2.3 Catalent Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2020-2025)
 11.2.4 Catalent Main Business Overview
 11.2.5 Catalent Latest Developments
 11.3 Thermo Fisher Scientific
 11.3.1 Thermo Fisher Scientific Company Information
 11.3.2 Thermo Fisher Scientific Small Molecule Drug CDMO Product Offered
 11.3.3 Thermo Fisher Scientific Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2020-2025)
 11.3.4 Thermo Fisher Scientific Main Business Overview
 11.3.5 Thermo Fisher Scientific Latest Developments
 11.4 Samsung Biologics
 11.4.1 Samsung Biologics Company Information
 11.4.2 Samsung Biologics Small Molecule Drug CDMO Product Offered
 11.4.3 Samsung Biologics Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2020-2025)
 11.4.4 Samsung Biologics Main Business Overview
 11.4.5 Samsung Biologics Latest Developments
 11.5 Fareva
 11.5.1 Fareva Company Information
 11.5.2 Fareva Small Molecule Drug CDMO Product Offered
 11.5.3 Fareva Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2020-2025)
 11.5.4 Fareva Main Business Overview
 11.5.5 Fareva Latest Developments
 11.6 WuXi AppTech
 11.6.1 WuXi AppTech Company Information
 11.6.2 WuXi AppTech Small Molecule Drug CDMO Product Offered
 11.6.3 WuXi AppTech Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2020-2025)
 11.6.4 WuXi AppTech Main Business Overview
 11.6.5 WuXi AppTech Latest Developments
 11.7 WuXi Biologics
 11.7.1 WuXi Biologics Company Information
 11.7.2 WuXi Biologics Small Molecule Drug CDMO Product Offered
 11.7.3 WuXi Biologics Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2020-2025)
 11.7.4 WuXi Biologics Main Business Overview
 11.7.5 WuXi Biologics Latest Developments
 11.8 Siegfried
 11.8.1 Siegfried Company Information
 11.8.2 Siegfried Small Molecule Drug CDMO Product Offered
 11.8.3 Siegfried Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2020-2025)
 11.8.4 Siegfried Main Business Overview
 11.8.5 Siegfried Latest Developments
 11.9 FUJIFILM Diosynth Biotechnologies
 11.9.1 FUJIFILM Diosynth Biotechnologies Company Information
 11.9.2 FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Product Offered
 11.9.3 FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2020-2025)
 11.9.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
 11.9.5 FUJIFILM Diosynth Biotechnologies Latest Developments
 11.10 Asymchem
 11.10.1 Asymchem Company Information
 11.10.2 Asymchem Small Molecule Drug CDMO Product Offered
 11.10.3 Asymchem Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2020-2025)
 11.10.4 Asymchem Main Business Overview
 11.10.5 Asymchem Latest Developments
 11.11 Pfizer CentreOne
 11.11.1 Pfizer CentreOne Company Information
 11.11.2 Pfizer CentreOne Small Molecule Drug CDMO Product Offered
 11.11.3 Pfizer CentreOne Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2020-2025)
 11.11.4 Pfizer CentreOne Main Business Overview
 11.11.5 Pfizer CentreOne Latest Developments
 11.12 Delpharm
 11.12.1 Delpharm Company Information
 11.12.2 Delpharm Small Molecule Drug CDMO Product Offered
 11.12.3 Delpharm Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2020-2025)
 11.12.4 Delpharm Main Business Overview
 11.12.5 Delpharm Latest Developments
 11.13 Recipharm
 11.13.1 Recipharm Company Information
 11.13.2 Recipharm Small Molecule Drug CDMO Product Offered
 11.13.3 Recipharm Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2020-2025)
 11.13.4 Recipharm Main Business Overview
 11.13.5 Recipharm Latest Developments
 11.14 AGC Pharma Chemicals
 11.14.1 AGC Pharma Chemicals Company Information
 11.14.2 AGC Pharma Chemicals Small Molecule Drug CDMO Product Offered
 11.14.3 AGC Pharma Chemicals Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2020-2025)
 11.14.4 AGC Pharma Chemicals Main Business Overview
 11.14.5 AGC Pharma Chemicals Latest Developments
 11.15 Boehringer Ingelheim
 11.15.1 Boehringer Ingelheim Company Information
 11.15.2 Boehringer Ingelheim Small Molecule Drug CDMO Product Offered
 11.15.3 Boehringer Ingelheim Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2020-2025)
 11.15.4 Boehringer Ingelheim Main Business Overview
 11.15.5 Boehringer Ingelheim Latest Developments
 11.16 Vetter
 11.16.1 Vetter Company Information
 11.16.2 Vetter Small Molecule Drug CDMO Product Offered
 11.16.3 Vetter Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2020-2025)
 11.16.4 Vetter Main Business Overview
 11.16.5 Vetter Latest Developments
 11.17 Curia
 11.17.1 Curia Company Information
 11.17.2 Curia Small Molecule Drug CDMO Product Offered
 11.17.3 Curia Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2020-2025)
 11.17.4 Curia Main Business Overview
 11.17.5 Curia Latest Developments
 11.18 Aenova
 11.18.1 Aenova Company Information
 11.18.2 Aenova Small Molecule Drug CDMO Product Offered
 11.18.3 Aenova Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2020-2025)
 11.18.4 Aenova Main Business Overview
 11.18.5 Aenova Latest Developments
 11.19 Porton
 11.19.1 Porton Company Information
 11.19.2 Porton Small Molecule Drug CDMO Product Offered
 11.19.3 Porton Small Molecule Drug CDMO Revenue, Gross Margin and Market Share (2020-2025)
 11.19.4 Porton Main Business Overview
 11.19.5 Porton Latest Developments
12 Research Findings and Conclusion

List of Tables
 Table 1. Small Molecule Drug CDMO Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
 Table 2. Small Molecule Drug CDMO Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
 Table 3. Major Players of FDF CDMO
 Table 4. Major Players of Packaging CDMO
 Table 5. Major Players of Clinical CDMO
 Table 6. Small Molecule Drug CDMO Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
 Table 7. Global Small Molecule Drug CDMO Market Size by Type (2020-2025) & ($ millions)
 Table 8. Global Small Molecule Drug CDMO Market Size Market Share by Type (2020-2025)
 Table 9. Small Molecule Drug CDMO Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
 Table 10. Global Small Molecule Drug CDMO Market Size by Application (2020-2025) & ($ millions)
 Table 11. Global Small Molecule Drug CDMO Market Size Market Share by Application (2020-2025)
 Table 12. Global Small Molecule Drug CDMO Revenue by Player (2020-2025) & ($ millions)
 Table 13. Global Small Molecule Drug CDMO Revenue Market Share by Player (2020-2025)
 Table 14. Small Molecule Drug CDMO Key Players Head office and Products Offered
 Table 15. Small Molecule Drug CDMO Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 Table 16. New Products and Potential Entrants
 Table 17. Mergers & Acquisitions, Expansion
 Table 18. Global Small Molecule Drug CDMO Market Size by Region (2020-2025) & ($ millions)
 Table 19. Global Small Molecule Drug CDMO Market Size Market Share by Region (2020-2025)
 Table 20. Global Small Molecule Drug CDMO Revenue by Country/Region (2020-2025) & ($ millions)
 Table 21. Global Small Molecule Drug CDMO Revenue Market Share by Country/Region (2020-2025)
 Table 22. Americas Small Molecule Drug CDMO Market Size by Country (2020-2025) & ($ millions)
 Table 23. Americas Small Molecule Drug CDMO Market Size Market Share by Country (2020-2025)
 Table 24. Americas Small Molecule Drug CDMO Market Size by Type (2020-2025) & ($ millions)
 Table 25. Americas Small Molecule Drug CDMO Market Size Market Share by Type (2020-2025)
 Table 26. Americas Small Molecule Drug CDMO Market Size by Application (2020-2025) & ($ millions)
 Table 27. Americas Small Molecule Drug CDMO Market Size Market Share by Application (2020-2025)
 Table 28. APAC Small Molecule Drug CDMO Market Size by Region (2020-2025) & ($ millions)
 Table 29. APAC Small Molecule Drug CDMO Market Size Market Share by Region (2020-2025)
 Table 30. APAC Small Molecule Drug CDMO Market Size by Type (2020-2025) & ($ millions)
 Table 31. APAC Small Molecule Drug CDMO Market Size by Application (2020-2025) & ($ millions)
 Table 32. Europe Small Molecule Drug CDMO Market Size by Country (2020-2025) & ($ millions)
 Table 33. Europe Small Molecule Drug CDMO Market Size Market Share by Country (2020-2025)
 Table 34. Europe Small Molecule Drug CDMO Market Size by Type (2020-2025) & ($ millions)
 Table 35. Europe Small Molecule Drug CDMO Market Size by Application (2020-2025) & ($ millions)
 Table 36. Middle East & Africa Small Molecule Drug CDMO Market Size by Region (2020-2025) & ($ millions)
 Table 37. Middle East & Africa Small Molecule Drug CDMO Market Size by Type (2020-2025) & ($ millions)
 Table 38. Middle East & Africa Small Molecule Drug CDMO Market Size by Application (2020-2025) & ($ millions)
 Table 39. Key Market Drivers & Growth Opportunities of Small Molecule Drug CDMO
 Table 40. Key Market Challenges & Risks of Small Molecule Drug CDMO
 Table 41. Key Industry Trends of Small Molecule Drug CDMO
 Table 42. Global Small Molecule Drug CDMO Market Size Forecast by Region (2026-2031) & ($ millions)
 Table 43. Global Small Molecule Drug CDMO Market Size Market Share Forecast by Region (2026-2031)
 Table 44. Global Small Molecule Drug CDMO Market Size Forecast by Type (2026-2031) & ($ millions)
 Table 45. Global Small Molecule Drug CDMO Market Size Forecast by Application (2026-2031) & ($ millions)
 Table 46. Lonza Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
 Table 47. Lonza Small Molecule Drug CDMO Product Offered
 Table 48. Lonza Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 49. Lonza Main Business
 Table 50. Lonza Latest Developments
 Table 51. Catalent Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
 Table 52. Catalent Small Molecule Drug CDMO Product Offered
 Table 53. Catalent Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 54. Catalent Main Business
 Table 55. Catalent Latest Developments
 Table 56. Thermo Fisher Scientific Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
 Table 57. Thermo Fisher Scientific Small Molecule Drug CDMO Product Offered
 Table 58. Thermo Fisher Scientific Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 59. Thermo Fisher Scientific Main Business
 Table 60. Thermo Fisher Scientific Latest Developments
 Table 61. Samsung Biologics Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
 Table 62. Samsung Biologics Small Molecule Drug CDMO Product Offered
 Table 63. Samsung Biologics Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 64. Samsung Biologics Main Business
 Table 65. Samsung Biologics Latest Developments
 Table 66. Fareva Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
 Table 67. Fareva Small Molecule Drug CDMO Product Offered
 Table 68. Fareva Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 69. Fareva Main Business
 Table 70. Fareva Latest Developments
 Table 71. WuXi AppTech Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
 Table 72. WuXi AppTech Small Molecule Drug CDMO Product Offered
 Table 73. WuXi AppTech Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 74. WuXi AppTech Main Business
 Table 75. WuXi AppTech Latest Developments
 Table 76. WuXi Biologics Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
 Table 77. WuXi Biologics Small Molecule Drug CDMO Product Offered
 Table 78. WuXi Biologics Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 79. WuXi Biologics Main Business
 Table 80. WuXi Biologics Latest Developments
 Table 81. Siegfried Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
 Table 82. Siegfried Small Molecule Drug CDMO Product Offered
 Table 83. Siegfried Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 84. Siegfried Main Business
 Table 85. Siegfried Latest Developments
 Table 86. FUJIFILM Diosynth Biotechnologies Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
 Table 87. FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Product Offered
 Table 88. FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 89. FUJIFILM Diosynth Biotechnologies Main Business
 Table 90. FUJIFILM Diosynth Biotechnologies Latest Developments
 Table 91. Asymchem Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
 Table 92. Asymchem Small Molecule Drug CDMO Product Offered
 Table 93. Asymchem Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 94. Asymchem Main Business
 Table 95. Asymchem Latest Developments
 Table 96. Pfizer CentreOne Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
 Table 97. Pfizer CentreOne Small Molecule Drug CDMO Product Offered
 Table 98. Pfizer CentreOne Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 99. Pfizer CentreOne Main Business
 Table 100. Pfizer CentreOne Latest Developments
 Table 101. Delpharm Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
 Table 102. Delpharm Small Molecule Drug CDMO Product Offered
 Table 103. Delpharm Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 104. Delpharm Main Business
 Table 105. Delpharm Latest Developments
 Table 106. Recipharm Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
 Table 107. Recipharm Small Molecule Drug CDMO Product Offered
 Table 108. Recipharm Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 109. Recipharm Main Business
 Table 110. Recipharm Latest Developments
 Table 111. AGC Pharma Chemicals Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
 Table 112. AGC Pharma Chemicals Small Molecule Drug CDMO Product Offered
 Table 113. AGC Pharma Chemicals Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 114. AGC Pharma Chemicals Main Business
 Table 115. AGC Pharma Chemicals Latest Developments
 Table 116. Boehringer Ingelheim Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
 Table 117. Boehringer Ingelheim Small Molecule Drug CDMO Product Offered
 Table 118. Boehringer Ingelheim Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 119. Boehringer Ingelheim Main Business
 Table 120. Boehringer Ingelheim Latest Developments
 Table 121. Vetter Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
 Table 122. Vetter Small Molecule Drug CDMO Product Offered
 Table 123. Vetter Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 124. Vetter Main Business
 Table 125. Vetter Latest Developments
 Table 126. Curia Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
 Table 127. Curia Small Molecule Drug CDMO Product Offered
 Table 128. Curia Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 129. Curia Main Business
 Table 130. Curia Latest Developments
 Table 131. Aenova Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
 Table 132. Aenova Small Molecule Drug CDMO Product Offered
 Table 133. Aenova Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 134. Aenova Main Business
 Table 135. Aenova Latest Developments
 Table 136. Porton Details, Company Type, Small Molecule Drug CDMO Area Served and Its Competitors
 Table 137. Porton Small Molecule Drug CDMO Product Offered
 Table 138. Porton Small Molecule Drug CDMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 139. Porton Main Business
 Table 140. Porton Latest Developments


List of Figures
 Figure 1. Small Molecule Drug CDMO Report Years Considered
 Figure 2. Research Objectives
 Figure 3. Research Methodology
 Figure 4. Research Process and Data Source
 Figure 5. Global Small Molecule Drug CDMO Market Size Growth Rate (2020-2031) ($ millions)
 Figure 6. Small Molecule Drug CDMO Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Figure 7. Small Molecule Drug CDMO Sales Market Share by Country/Region (2024)
 Figure 8. Small Molecule Drug CDMO Sales Market Share by Country/Region (2020, 2024 & 2031)
 Figure 9. Global Small Molecule Drug CDMO Market Size Market Share by Type in 2024
 Figure 10. Small Molecule Drug CDMO in Pharmaceutical Company
 Figure 11. Global Small Molecule Drug CDMO Market: Pharmaceutical Company (2020-2025) & ($ millions)
 Figure 12. Small Molecule Drug CDMO in Biotechnology Company
 Figure 13. Global Small Molecule Drug CDMO Market: Biotechnology Company (2020-2025) & ($ millions)
 Figure 14. Small Molecule Drug CDMO in Other
 Figure 15. Global Small Molecule Drug CDMO Market: Other (2020-2025) & ($ millions)
 Figure 16. Global Small Molecule Drug CDMO Market Size Market Share by Application in 2024
 Figure 17. Global Small Molecule Drug CDMO Revenue Market Share by Player in 2024
 Figure 18. Global Small Molecule Drug CDMO Market Size Market Share by Region (2020-2025)
 Figure 19. Americas Small Molecule Drug CDMO Market Size 2020-2025 ($ millions)
 Figure 20. APAC Small Molecule Drug CDMO Market Size 2020-2025 ($ millions)
 Figure 21. Europe Small Molecule Drug CDMO Market Size 2020-2025 ($ millions)
 Figure 22. Middle East & Africa Small Molecule Drug CDMO Market Size 2020-2025 ($ millions)
 Figure 23. Americas Small Molecule Drug CDMO Value Market Share by Country in 2024
 Figure 24. United States Small Molecule Drug CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 25. Canada Small Molecule Drug CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 26. Mexico Small Molecule Drug CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 27. Brazil Small Molecule Drug CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 28. APAC Small Molecule Drug CDMO Market Size Market Share by Region in 2024
 Figure 29. APAC Small Molecule Drug CDMO Market Size Market Share by Type (2020-2025)
 Figure 30. APAC Small Molecule Drug CDMO Market Size Market Share by Application (2020-2025)
 Figure 31. China Small Molecule Drug CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 32. Japan Small Molecule Drug CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 33. South Korea Small Molecule Drug CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 34. Southeast Asia Small Molecule Drug CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 35. India Small Molecule Drug CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 36. Australia Small Molecule Drug CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 37. Europe Small Molecule Drug CDMO Market Size Market Share by Country in 2024
 Figure 38. Europe Small Molecule Drug CDMO Market Size Market Share by Type (2020-2025)
 Figure 39. Europe Small Molecule Drug CDMO Market Size Market Share by Application (2020-2025)
 Figure 40. Germany Small Molecule Drug CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 41. France Small Molecule Drug CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 42. UK Small Molecule Drug CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 43. Italy Small Molecule Drug CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 44. Russia Small Molecule Drug CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 45. Middle East & Africa Small Molecule Drug CDMO Market Size Market Share by Region (2020-2025)
 Figure 46. Middle East & Africa Small Molecule Drug CDMO Market Size Market Share by Type (2020-2025)
 Figure 47. Middle East & Africa Small Molecule Drug CDMO Market Size Market Share by Application (2020-2025)
 Figure 48. Egypt Small Molecule Drug CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 49. South Africa Small Molecule Drug CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 50. Israel Small Molecule Drug CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 51. Turkey Small Molecule Drug CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 52. GCC Countries Small Molecule Drug CDMO Market Size Growth 2020-2025 ($ millions)
 Figure 53. Americas Small Molecule Drug CDMO Market Size 2026-2031 ($ millions)
 Figure 54. APAC Small Molecule Drug CDMO Market Size 2026-2031 ($ millions)
 Figure 55. Europe Small Molecule Drug CDMO Market Size 2026-2031 ($ millions)
 Figure 56. Middle East & Africa Small Molecule Drug CDMO Market Size 2026-2031 ($ millions)
 Figure 57. United States Small Molecule Drug CDMO Market Size 2026-2031 ($ millions)
 Figure 58. Canada Small Molecule Drug CDMO Market Size 2026-2031 ($ millions)
 Figure 59. Mexico Small Molecule Drug CDMO Market Size 2026-2031 ($ millions)
 Figure 60. Brazil Small Molecule Drug CDMO Market Size 2026-2031 ($ millions)
 Figure 61. China Small Molecule Drug CDMO Market Size 2026-2031 ($ millions)
 Figure 62. Japan Small Molecule Drug CDMO Market Size 2026-2031 ($ millions)
 Figure 63. Korea Small Molecule Drug CDMO Market Size 2026-2031 ($ millions)
 Figure 64. Southeast Asia Small Molecule Drug CDMO Market Size 2026-2031 ($ millions)
 Figure 65. India Small Molecule Drug CDMO Market Size 2026-2031 ($ millions)
 Figure 66. Australia Small Molecule Drug CDMO Market Size 2026-2031 ($ millions)
 Figure 67. Germany Small Molecule Drug CDMO Market Size 2026-2031 ($ millions)
 Figure 68. France Small Molecule Drug CDMO Market Size 2026-2031 ($ millions)
 Figure 69. UK Small Molecule Drug CDMO Market Size 2026-2031 ($ millions)
 Figure 70. Italy Small Molecule Drug CDMO Market Size 2026-2031 ($ millions)
 Figure 71. Russia Small Molecule Drug CDMO Market Size 2026-2031 ($ millions)
 Figure 72. Egypt Small Molecule Drug CDMO Market Size 2026-2031 ($ millions)
 Figure 73. South Africa Small Molecule Drug CDMO Market Size 2026-2031 ($ millions)
 Figure 74. Israel Small Molecule Drug CDMO Market Size 2026-2031 ($ millions)
 Figure 75. Turkey Small Molecule Drug CDMO Market Size 2026-2031 ($ millions)
 Figure 76. Global Small Molecule Drug CDMO Market Size Market Share Forecast by Type (2026-2031)
 Figure 77. Global Small Molecule Drug CDMO Market Size Market Share Forecast by Application (2026-2031)
 Figure 78. GCC Countries Small Molecule Drug CDMO Market Size 2026-2031 ($ millions)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Lonza|||Catalent|||Thermo Fisher Scientific|||Samsung Biologics|||Fareva|||WuXi AppTech|||WuXi Biologics|||Siegfried|||FUJIFILM Diosynth Biotechnologies|||Asymchem|||Pfizer CentreOne|||Delpharm|||Recipharm|||AGC Pharma Chemicals|||Boehringer Ingelheim|||Vetter|||Curia|||Aenova|||Porton

Frequently Asked Questions

What is the USP of the report? expand_more
Small Molecule Drug CDMO report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
What are the key content of the report? expand_more
Small Molecule Drug CDMO report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
What are the value propositions and opportunities offered in this market research report? expand_more
Small Molecule Drug CDMO report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.